Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Shares Outstanding (2016 - 2019)

Historic Shares Outstanding for Soleno Therapeutics (SLNO) over the last 7 years, with Q3 2019 value amounting to $31.8 million.

  • Soleno Therapeutics' Shares Outstanding rose 4832.25% to $31.8 million in Q3 2019 from the same period last year, while for Sep 2019 it was $31.8 million, marking a year-over-year increase of 4832.25%. This contributed to the annual value of $31.8 million for FY2018, which is 6505.65% up from last year.
  • Soleno Therapeutics' Shares Outstanding amounted to $31.8 million in Q3 2019, which was up 4832.25% from $31.8 million recorded in Q2 2019.
  • Soleno Therapeutics' Shares Outstanding's 5-year high stood at $31.8 million during Q2 2019, with a 5-year trough of $2.8 million in Q4 2015.
  • Its 5-year average for Shares Outstanding is $21.5 million, with a median of $21.4 million in 2018.
  • Per our database at Business Quant, Soleno Therapeutics' Shares Outstanding tumbled by 5858.27% in 2015 and then surged by 47303.41% in 2017.
  • Soleno Therapeutics' Shares Outstanding (Quarter) stood at $2.8 million in 2015, then grew by 19.75% to $3.4 million in 2016, then skyrocketed by 473.03% to $19.2 million in 2017, then soared by 65.06% to $31.8 million in 2018, then rose by 0.12% to $31.8 million in 2019.
  • Its last three reported values are $31.8 million in Q3 2019, $31.8 million for Q2 2019, and $31.8 million during Q1 2019.